// App-Quantinova.ai

: Efficacy of reslizumab in adults with severe eosinophilic asthma with ≥3 exacerbations in the previous year: analyses at weeks 16 and 52 of two placebo-controlled phase 3 trials

Researchers

Presenter

  • Anoop Chauhan

Principal Investigators

  • Margaret Garin

  • Shawn Sun

Medical Centers

  • Portsmouth Hospital NHS Trust, Portsmouth, United Kingdom

  • Teva Pharmaceutical Industries, Frazer, United States of America

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • N/A

Drug/Treatment

  • Reslizumab

Outcome

  • N/A

Study Design

  • Placebo Control

  • Multicenteric

  • Controlled

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved